KRAS as a druggable target in NSCLC: Rising like a phoenix after decades of development failures
Alex Friedlaender, Alexander Drilon, Glen J. Weiss, Giuseppe Luigi Banna, Alfredo Addeo
Topics & Concepts
KRASMedicineCancer researchDruggabilityCancerMutationLung cancerOncologyBioinformaticsInternal medicineColorectal cancerBiologyGeneticsGeneMelanoma and MAPK PathwaysLung Cancer Treatments and MutationsMicrobial Natural Products and Biosynthesis